Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 12 Nov 2025 for Evommune, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
David E. Cohen: trading record in brief
Filings by David E. Cohen span 4 companies, the busiest being Dermira, Inc., Connetics Corp and Timber Pharmaceuticals, Inc. Between 22 May 2006 and 7 November 2025, the trades on record add up to 16 filings.
Sales make up the whole of the open-market record (8 sales, €105k). Outside the open market, there are 3 share grants and 2 option exercises.
The newest entry dates from 12 November 2025: a transaction, in Evommune, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David E. Cohen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
6,056 sharesCommon StockSEC:0001347383-25-000009:0
4,100 shares0Common Stock, par value $0.001 per shareSEC:0001437749-23-010513:0
100,000 shares0Common Stock, par value $0.001 per shareSEC:0001104659-22-047218:0
3 of 3 declarations
